Weight Loss Medications

Singing River Weight Loss Center offers a full range of weight loss solutions, including medication weight loss options. Learn more about GLP-1 medications prescribed for weight loss such as semaglutide and tirzepatide.

Advances in treatment for diabetes and obesity are providing patients with new options for losing weight. When you meet with a provider at Singing River Weight Loss, you’ll discuss your health, your weight loss goals, and what surgical and non-surgical options may be best for you. You can take weight loss medication prior to and even after surgery if your providers think it is appropriate.

Make an Appointment

Start your weight loss journey by filling out a new patient packet. After you’ve submitted your information, Singing River Weight Loss will reach out to schedule your first appointment.

New Patient Packet

GLP-1 Agonist Weight Loss Drugs

A new group of medications known as GLP-1 agonists are prescribed to help patients lose weight.

How GLP-1s Work

GLP-1s mimic a hormone produced in the small intestine that increases the sensitivity to the insulin your body produces, decreasing the amount of hunger hormone your body makes. They also act on the “reward centers” in your brain to suppress appetite.

Effectiveness

GLP-1 medications are effective in reducing hunger, and in combination with lifestyle modifications, are proven to result in weight loss. Even individuals who have previously struggled to lose weight with other approaches or diets have been seen to lose weight.

Studies have demonstrated that GLP-1s reduce appetite, improve control of eating, reduce food cravings and improve glycemic control. The greatest weight loss benefits are observed when they are used in combination with lifestyle changes, such as consistent exercise.

Benefits

Weight LossImproved Fertility
Cardiovascular BenefitsImprovement of PCOS
Smoking CessationNeuroprotective

Semaglutide

Semaglutide (brand names: Wegovy, Ozempic) is a drug developed to lower blood sugar levels and reduce the risk of major cardiovascular events such as heart attack or stroke in type two diabetes patients. After seeing its positive effects in this population and its common assistance in weight loss, Semaglutide received official approval in 2021 to be used in patients who might be struggling to lose weight.

In a recent study, after 68 weeks, patients saw between 15-20% total body weight reduction.

AdministrationApproved For
Weekly self-administered injection– Adults and pediatric patients aged 12 years and older with obesity (BMI 30+)

– Adults with overweight in the presence of at least one weight-related comorbid condition (BMI 27+)

Liraglutide

Liraglutide (brand names: Saxenda, Victoza) was the first GLP-1 medication approved for treatment of children (12+) and adults with obesity in 2014.

While semaglutide is more frequently prescribed than liraglutide, Saxenda may be more convenient for some patients. The drug is injected daily and has a lower potency with a shorter half life. Some patients may prefer to start with less potent medication and only switch to a stronger option when necessary. Depending on their insurance carrier, the drug may also be more affordable.

AdministrationApproved For
Daily self-administered injection– Adults and pediatric patients aged 12 years and older with obesity (BMI 30+)

– Adults with overweight in the presence of at least one weight-related comorbid condition (BMI 27+)

Make an Appointment

Start your weight loss journey by filling out a new patient packet. After you’ve submitted your information, Singing River Weight Loss will reach out to schedule your first appointment.

New Patient Packet

Tirzepatide

Tirzepatide (brand names: Zepbound, Mounjaro) is not only a GLP-1 medication, but a Gastric Inhibitory Polypetide (GIP) as well. GIP is another hormone that focuses on the early phase of insulin release. By combining these two hormones in the drug tirzepatide, the medication potentially provides additional benefits compared to a single hormone like semaglutide. Patients may be able to achieve the same therapeutic effect at lower doses and therefore reduce their risk of side effects.

Tirzepatide was approved as the drug Mounjaro in early 2022 for patients with diabetes and then as the drug Zepbound for patients with obesity in November of 2023. Tirzepatide is not yet approved for pediatric patients.

AdministrationApproved For
Weekly self-administered injection– Adults with obesity (BMI 30+)

– Adults with overweight in the presence of at least one weight-related comorbid condition (BMI 27+)

Frequently Asked Questions

How is the Treatment Administered?

Semaglutide is self-administered as a subcutaneous injection (shot) once weekly. This medication is generally well-tolerated and it can be taken long-term. 

Will my insurance cover semaglutide or other GLP-1 medications for weight loss?

This depends on your insurance coverage and what medication you are placed on.

Can I be in the surgery program and be on weight loss medication?

YES! You can take weight loss medication prior to and even after surgery if your providers think it
is appropriate.

How much weight can I expect to lose on semaglutide or other weight loss medication?

Studies have shown that the average person lost around 10-20% of their bodyweight with the use of semaglutide. For example, a patient weighing 250 lbs can expect to lose around 25-50 lbs. 

What’s my BMI?